Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo

por Neldeborg, Signe, Soerensen, Johannes Frasez, Møller, Charlotte Thornild, Bill, Marie, Gao, Zongliang, Bak, Rasmus O., Holm, Kasper, Sorensen, Boe, Nyegaard, Mette, Luo, Yonglun, Hokland, Peter, Stougaard, Magnus, Ludvigsen, Maja, Holm, Christian Kanstrup
Publicado 2023